A conspiracy Theory by the competition
There is no valid reason for this sell off , there is a concerted effort to short and discredit SSH by the competition ? who else is conducting a trial in Europe and has SSH board observation rights ?
The FDA validated safety and efficacy by allowing the trial to re-commence ,
SSH could shoot to the up side on enrolments this quarter , over 60 in the pipeline and 27 sites open for business and building , the benefit to patients implanted is immediate , this news will flow , this sell off is manipulated to suit , I have no doubt that the FDA will approve C-Pulse and shortly after CP2 , only a matter of time , time to hold tight.
SHC Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held